Stem Cell Diabetes Treatment in Thailand Offers Hope For Exploding Asian Diabetic Population

Bangkok, Thailand - Thai Medical Vacation an independent medical facilitator specializing in securing advanced medical tours and adult stem cell treatment in Asia. Thailand, today announced an exclusive partnership to provide adult autologous stem cell treatments for patients suffering from Diabetes Mellitus. The agreement increases its position in providing a proven medical treatments to the over 180 million diabetics worldwide. The International Diabetes Federation estimates there will be more than half a billion patients by 2030, China alone has over 90 million sufferers today. “Unfortunately, sedentary lifestyles and diets rich in refined processed carbs are trends I don’t see changing anytime soon.” said Sal Amer, Chief Financial Officer of ThaiMedicalVacation.com.  

“The goal is simple, our treatment objectives and protocols call for complete abolition or reduction of insulin requirement by greater than 50% by the end of 6 months. ”Major contributors to the degenerative effects of diabetes are hyperglycemia (high blood sugar) and hypoglycemic events (acute low blood sugar). Recent studies suggest that even some oral diabetes medications can contribute to heart failure. It is critical that men, women and children who are diagnosed with diabetes seek treatment to reduce hyperglycemia and hypoglycemic events that will in time trigger these dangerous degenerative conditions. The new treatment protocol for stem cell diabetes mellitus type I and II require an estimated 12-14 day medical vacation to Thailand.

Contact Information

Lala P. Wong

Vice President

Thai Medical Vacation

(1) (888) 407-1584

media@thaimedicalvacation.com